Narrative review / 2013
Elevated phosphate levels are associated with vascular calcification, cardiovascular changes, and increased mortality.
Evidence from in vitro, clinical, and epidemiological studies indicates that elevated phosphate is associated with vascular calcification and mortality. High phosphate is linked to vessel wall thickness, arterial stiffness, and coronary calcification in children on dialysis, as well as mortality in adult dialysis patients. These cardiovascular changes are also observed in pre-dialysis CKD and in subjects with normal renal function who have high phosphate. Phosphate binders reduce serum phosphate, a decrease linked to improved survival, while raised phosphate triggers FGF-23, which may also act as an independent cardiovascular risk factor.
Shows an association, not proof of cause and effect.
- Study type
- Narrative review
- Who was studied
- Patients with CKD, dialysis patients, and individuals with normal renal function
- What was measured
- Vascular calcification, cardiovascular changes, and mortality
THE PAPER
Phosphate is a vascular toxin.
Shroff R. Pediatr Nephrol, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.